Cell Engineering and Molecular Pharming for Biopharmaceuticals

Abdullah, MA (2008) Cell Engineering and Molecular Pharming for Biopharmaceuticals. [Citation Index Journal]

[thumbnail of The Open Medicinal Chemistry Journal, 2008, 2, 49-61] PDF (The Open Medicinal Chemistry Journal, 2008, 2, 49-61)
Restricted to Registered users only

Download (426kB)


Biopharmaceuticals are often produced by recombinant E. coli or mammalian cell lines. This is usually
achieved by the introduction of a gene or cDNA coding for the protein of interest into a well-characterized strain of producer
cells. Naturally, each recombinant production system has its own unique advantages and disadvantages. This paper
examines the current practices, developments, and future trends in the production of biopharmaceuticals. Platform technologies
for rapid screening and analyses of biosystems are reviewed. Strategies to improve productivity via metabolic
and integrated engineering are also highlighted.

Item Type: Citation Index Journal
Subjects: R Medicine > R Medicine (General)
Departments / MOR / COE: Research Institutes > Institute for Health Analytics
Depositing User: Dr Mohd Azmuddin Abdullah
Date Deposited: 05 Sep 2011 00:38
Last Modified: 19 Jan 2017 08:26
URI: http://scholars.utp.edu.my/id/eprint/6387

Actions (login required)

View Item
View Item